Home » Topics » BioWorld Science

BioWorld Science
RSS

BTS-73947: new D1/D5 antagonist from Knoll

Aug. 16, 1996

Roche profiles pharmacokinetics, pharmacodynamics of new benzodiazepine

Aug. 16, 1996

first clinical study results reported for Ro-48-6791

Aug. 16, 1996

LY-23728, 5-HT2B antagonist reported by Lilly

Aug. 16, 1996

5-HT2 receptor ligands reported by Allelix

Aug. 16, 1996

Conceptus begins clinical testing of STARRT falloposcopy system

Aug. 16, 1996

Histamine H3 agonist increases slow-wave sleep in rats

Aug. 16, 1996

Home Access HIV testing system cleared for marketing in U.S.

Aug. 16, 1996

BCT launched in U.S.

Aug. 16, 1996

Bard to comarket ProstaScint with Cytogen

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...